Abstract:Abstract Aims To investigate the prevalence of familial hypercholesterolaemia (FH) and compare the performance of clinical criteria and genetic testing in patients undergoing coronary angiography. Methods and results The prevalence of FH was determined with the Dutch Lipid Clinical Network (DLCN), US ‘Make Early Diagnosis to Prevent Early Death’ (US-MEDPED), Simon Broome (SB) criteria, the ‘familial hypercholesterolaemia case ascertainment tool’ (FAMCAT), and a clinical algorithm. Genetic screening was conducted with a custom array from Affymetrix (CARRENAL array) harbouring 944 FH mutations. The study cohort consisted of 3267 patients [78.6% with coronary artery disease (CAD)]. FH was diagnosed in 2.8%, 2.2%, 3.9%, and 7.9% using the DLCN, US-MEDPED, SB criteria, and the FAMCAT. The clinical algorithm identified the same patients as the SB criteria. Pathogenic FH mutations were found in 1.2% (1.2% in patients with CAD, 1.0% in patients without CAD). FH was more frequently diagnosed in younger patients. With genetic testing as reference, the clinical criteria achieved areas under the ROC curve [area under the curves (AUCs)] in the range of 0.56–0.68. Using only low-density lipoprotein cholesterol (LDL-C) corrected for statin intake, an AUC of 0.68 was achieved. Conclusion FH is up to four-fold more prevalent in patients undergoing coronary angiography than in contemporary cohorts representing the general population. Different clinical criteria yield substantially different diagnosis rates, overestimating the prevalence of FH compared with genetic testing. LDL-C testing alone may be sufficient to raise the suspicion of FH, which then needs to be corroborated by genetic testing. Lay summary In this study, we investigated the frequency of familial hypercholesterolaemia—a common genetic condition leading to markedly elevated low-density lipoprotein (LDL) cholesterol and increased risk of atherosclerosis—in 3267 patients undergoing coronary angiography according to commonly used diagnostic scoring systems and genetic testing. Genetically confirmed familial hypercholesterolaemia was four-fold more prevalent in patients undergoing coronary angiography compared with contemporary cohorts representing the general population, and was more often diagnosed in younger patients.Compared with genetic testing—the gold standard to diagnose familial hypercholesterolaemia—the diagnostic scoring systems only modestly discriminated between healthy individuals and those with familial hypercholesterolaemia. Importantly, LDL cholesterol testing alone provided equivalent diagnostic information compared with any of the scores.

Prevalence of Familial Hypercholesterolemia in Patients with Premature Myocardial Infarction

Effects of Familial Hypercholesterolemia-Associated Genes on the Phenotype of Premature Myocardial Infarction

[The Diagnostic Value of Genetic Testing in Familial Hypercholesterolemia in Patients with Premature Myocardial Infarction].

Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome

Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35–75 years: Results from China PEACE Million Persons Project

Prevalence of genetically diagnosed familial hypercholesterolemia in Vietnamese patients with premature acute myocardial infarction

Familial Hypercholesterolemia: Current Limitations and Future Breakthroughs

Genetic Basis of Index Patients with Familial Hypercholesterolemia in Chinese Population: Mutation Spectrum and Genotype-Phenotype Correlation

The Genetic Spectrum of Familial Hypercholesterolemia in the Central South Region of China.

Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels

Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study

Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia.

Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

The prevalence and related factors of familial hypercholesterolemia in rural population of China using Chinese modified Dutch Lipid Clinic Network definition

Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study

GW24-e3589 A novel mutation 1587_1588 del2 of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia in a Chinese family

Mutation Detection in Chinese Patients with Familial Hypercholesterolemia.

Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study

The relationship between early-onset coronary artery disease and familial hypercholesterolemia: a cohort study based on the Hakka population in Meizhou, China

Clinical and angiographic characteristics of patients with familial hypercholesterolemia presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography